Infective endocarditis--a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality.
about
Infective endocarditis epidemiology over five decades: a systematic reviewMechanisms of infective endocarditis: pathogen-host interaction and risk states.Infective endocarditisClinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patientsPrognostic factors in left-sided endocarditis: results from the Andalusian multicenter cohortNew perspectives of infections in cardiovascular diseaseNon-nosocomial healthcare-associated infective endocarditis in Taiwan: an underrecognized disease with poor outcomeClinical features and outcome of infective endocarditis in yemeni patients treated with empirical antibiotic therapy.Healthcare-associated infective endocarditis: a case series in a referral hospital from 2006 to 2011.Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the EuInfections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphineEnterococcal endocarditis: can we win the war?The changing face of infective endocarditis.Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia.Infective mitral valve endocarditis after transapical aortic valve implantation.Health care-associated native valve endocarditis: importance of non-nosocomial acquisition.Methicillin resistance and risk factors for embolism in Staphylococcus aureus infective endocarditis.Candida albicans tricuspid and pulmonic valve endocarditis: challenge of relapsing risk and role of combined medical treatment and surgery.Efficacy of antibiotic prophylactic regimens for the prevention of bacterial endocarditis of oral origin.Current Epidemiology and Outcome of Infective Endocarditis: A Multicenter, Prospective, Cohort Study.Endocarditis in Greenland with special reference to endocarditis caused by Streptococcus pneumoniae.Treatment strategies for infective endocarditis.Infective endocarditis in congenital heart disease.Infective endocarditis in intravenous drug abusers: an update.Acute endocarditis in intravenous drug users: a case report and literature review.Effect of a single bolus of methylene blue prophylaxis on vasopressor and transfusion requirement in infective endocarditis patients undergoing cardiac surgery.Endocarditis as a Marker for New Epidemics of Injection Drug Use.Evaluating treatment options for patients with infective endocarditis: when is it the right time for surgery?Infective endocarditis in an intravenous drug abuser.Heart valves should not be routinely cultured.Infective endocarditis in patients with congenitally malformed hearts: characterization of the syndrome in a developing country.Contemporary epidemiology and prognosis of septic shock in infective endocarditis.Infective endocarditis in congenital heart disease: a frequent community-acquired complication.Incidence of infective endocarditis among patients considered at high risk.Infektiöse EndokarditisDetection of spleen, kidney and liver infarcts by abdominal computed tomography does not affect the outcome in patients with left-side infective endocarditis
P2860
Q27024815-27424AE4-E4C8-4C86-B37F-7016867E1294Q30317657-F010E1ED-8AC6-4D80-B89D-D3A09AD59A67Q30458409-D6778C25-7338-40F2-9369-3C16985BA41EQ33257127-BB084CFA-1E46-4DE9-91A3-545A351BE55BQ33526060-0AAB09AB-B147-4298-8744-840D5008F362Q33587960-8B2BE0A4-2F95-4916-BC27-075FBAB6B787Q33995221-68AD9A32-E9B8-4053-B063-57481D55A5F2Q34244047-5305D158-9E2B-444D-B67F-5ADBF8540B08Q34387826-BDC64B18-3179-444A-B563-6ED50CBB93CCQ34611253-2B2CDA44-58D1-45D0-A973-20FE4B0C6549Q35201603-CFA4462A-D473-4B20-B752-C6CC181D58ACQ35610638-41A940A1-E042-4B0A-9D03-7315D0CA644BQ35771025-105F2988-D1E8-4B50-BB35-86F3C1964146Q36224748-ED4BD4BE-E2C6-4B0A-8391-2BC624FAF923Q36599744-4FF00AB8-1251-487F-A471-5856BACE4485Q36763637-575D3A93-8F49-4BAB-BBF1-6743B118DDA1Q36848018-E77CDC39-1ACA-4C12-AE6B-E587BDE14A2CQ36852875-7593E32C-B326-488D-99FF-2A6D3D51CFBDQ37014023-16C160BF-4B49-45A9-A28D-B165B7EE5FFDQ37176221-B3E01EB1-A90B-48B8-ADF2-C9E7C3B6F563Q37633642-B4732E76-2737-4CFC-A651-1F12FA537622Q37681564-083F744C-3898-4340-965A-DB020C906D5FQ37902944-4CE2A75A-9284-4507-9299-B7F475811422Q38020116-B21C1F71-A60E-47D4-9B67-5639425665C5Q38123818-7BA7F97D-CF60-44D0-86CA-364B3E13D075Q38458772-FFBD1794-288B-4CFF-BF89-0B3C6E71F8E8Q39028798-CE30035E-6375-4B0B-9B23-C1FFFE18BAF0Q39515222-DD7708C2-686A-4BF8-889C-56DD189990A2Q41018141-4604AC86-C9A9-4364-A378-486283786478Q42148824-B293367E-2AD6-4F2D-88F7-70C835913213Q43849515-C3ADCCBE-2598-438E-8F03-2C0264F627B1Q44480634-12139E46-B5DE-4E4A-8B78-C71138225ECDQ46018674-A405679F-1629-4C09-989A-E1B92BBB6AF2Q49825730-8A94885A-0104-4A34-A48B-9ABC5A721796Q55109715-8C550032-7C36-4C32-87F0-0A5CD422D733Q57652771-3937620F-BE32-43A2-9AC1-4AD08AB5EC19
P2860
Infective endocarditis--a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Infective endocarditis--a pros ...... s, and still a high mortality.
@ast
Infective endocarditis--a pros ...... s, and still a high mortality.
@en
Infective endocarditis--a pros ...... s, and still a high mortality.
@nl
type
label
Infective endocarditis--a pros ...... s, and still a high mortality.
@ast
Infective endocarditis--a pros ...... s, and still a high mortality.
@en
Infective endocarditis--a pros ...... s, and still a high mortality.
@nl
prefLabel
Infective endocarditis--a pros ...... s, and still a high mortality.
@ast
Infective endocarditis--a pros ...... s, and still a high mortality.
@en
Infective endocarditis--a pros ...... s, and still a high mortality.
@nl
P2093
P1433
P1476
Infective endocarditis--a pros ...... s, and still a high mortality.
@en
P2093
García Fernández MA
Menasalvas A
Vasallo FJ
del Mar Moreno M
P304
P356
10.1097/00005792-200109000-00003
P407
P577
2001-09-01T00:00:00Z